Software & Services
Etherstack Plc (ASX:ESK) has invested in excess of $20 million into our suite of intellectual property assets over an extended period and has developed a substantial intellectual property portfolio that generates a diverse range of revenue streams from multiple technology areas.
iSIgnthis Ltd (ASX:ISX) (FRA:TA8) is pleased to advise that it has met its certification requirements with the Central Bank of Lithuania for SEPA Instant thresholds to be lifted from EUR15,000 per transaction to EUR100,000 per transaction limit, as from 1st July 2020.
Etherstack plc (ASX:ESK) shareholders wishing to participate in the on line Annual general meeting are requested to email shareholderhelp@etherstack.com to obtain the access codes for attending the on line meeting.
The Board of BetMakers Technology Group Limited (ASX:BET) (FRA:T07) is pleased to announce that it has now secured the rights to manage on-course Fixed Odds betting at New Jersey race track Monmouth Park using Fixed Odds terminals and kiosks for cash betting.
Etherstack plc (ASX:ESK) is pleased to announce its Australian subsidiary, Auria Wireless Pty Limited, has entered a contract with Perth base system integrator, CSE Crosscom, to provide Auria's P25 digital radio network technology to CSE Crosscom's customer, being a mining company with activities in the Pilbara region of north-west Western Australia.
iSignthis Ltd (ASX:ISX) "the Company" discloses that as foreshadowed in the announcement of 20th February 2020, the Company's subsidiary Probanx Holdings Ltd has taken up the option to participate in the NSX Limited (ASX:NSX) capital raise.
iSignthis Ltd (ASX:ISX) (FRA:TA8) is pleased to announce its 4th consecutive positive quarterly operating cash flow contained in the Appendix 4C and our quarterly business activity report.
The Board of BetMakers Technology Group Ltd (ASX:BET) (FRA:T07) is pleased to release its quarterly cash flow statement and quarterly activities report for the quarter ending 31 March 2020.
iSignthis Ltd (ASX:ISX) (FRA:TA8) is pleased to announce its 4th consecutive positive quarterly operating cash flow contained in the Appendix 4C and our quarterly business activity report.
The Board of BetMakers Technology Group Limited (ASX:BET) (FRA:T07) is pleased to announce that the Company has signed agreements with two of Australia's premier on-course rails bookmakers - Rob Waterhouse and Mark Sampieri - to launch their individual betting operations into the online wagering market.
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Deep Yellow Limited (ASX:DYL) Exploration Update
- Central Petroleum Limited (ASX:CTP) Appoints Mr Joel Riddle as Director
- Central Petroleum Limited (ASX:CTP) Strategic Expansion Into the Cooper and Otway Basins
- Beetaloo Energy Australia Limited (ASX:BTL) Carpentaria-5H Flow Testing Update
- Central Petroleum Limited (ASX:CTP) Sub-Salt Exploration Permit Sale Update
- Basin Energy Ltd (ASX:BSN) Completes Phase One Drilling and Expands Sybella-Barkly
Life Sciences
- BPH Energy Limited (ASX:BPH) Raises $1.2M to Accelerate Funding of Hydrocarbon and Cortical Investments
- Proteomics International Laboratories Ltd (ASX:PIQ) US Lab Accredited by College of American Pathologists - Extends Precision Dx Lab
- Proteomics International Laboratories Ltd (ASX:PIQ) US Patent Secured for PromarkerEso Diagnostic Test for Throat Cancer
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Changes How Doctors Manage Diabetic Kidney Disease - Study Published
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Predicts Risk of DKD in Aboriginal Australians
- TempraMed Technologies Ltd. (CNSX:VIVI) Exclusive Commercial Distribution Agreement with Turkish Medical Device Supplier































